Search

Research
CONNECT-CP (A Clinical Research Program to Improve Connection, Access and Translation of Evidence in Cerebral Palsy)More details coming soon.
Research
Tissue resident memory T cells: putting cancer cells to sleep and a target for therapyTissue resident memory T cells are cancer killing immune cells that have emerged as key players in immune-mediated control of solid cancers, as well as being markers of prognosis and predictors of response to immunotherapy.

Research
Bright Tomorrows Start Today (Parent App)The Bright Tomorrows app developed at The Kids Research Institute Australia aims to assist parents of children aged 0-5 years to support their child to develop the building blocks of several essential life skills.
Research
Early Moves ProjectThe Early Moves study is investigating whether a baby’s early movements can predict learning difficulties later in childhood.
Research
Tonsil organ model to evaluate carriage, disease mechanisms and therapeutic interventions for treatment and prevention of GAS infectionsTonsil organ model to evaluate carriage, disease mechanisms and therapeutic interventions for treatment and prevention of Group A Streptococcal infections.

AuStralian Collaboration to Enhance Neuro-Development
Research
Developing a ‘Food Atlas’ for Western Australia to map, measure and monitor food accessThis unique interdisciplinary project, funded by Healthway, aims to develop a Food Atlas tool for mapping, measuring, and monitoring food access across Western Australia.
Research
Kids are not small adults, Identifying age-dependent drug targets in paediatric oncologyCancers in children are very different to cancers in adults. However, most therapeutic strategies are designed explicitly for adult cancers, and then used in children if proven safe.
Research
Incorporating Children's VoicesInforming urban planning and policy development to grow equitable access to healthy environments for young people and their families.
Research
Developing and characterising juvenile models of aggressive paediatric brain cancers for the evaluation of novel immunotherapies.While profound treatment responses have been realised using immunotherapy for some cancer types, this is yet to be seen for paediatric brain cancer patients.